ELI LILLY & Co — Director's Dealing 2014

Jul 28, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-07-25

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-25	Common Stock	S	30000	$63.90	Disposed	52798	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1578	Indirect
Common Stock	7635	Indirect
Common Stock	1568	Indirect

Footnotes

F1: Reporting person disclaims beneficial ownership of these shares.